ELIZABETH LOCCISANO: Open Payments
NPI 1679298921 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 26 payments from 14 companies in 2025. Trend: 2023 $17 · 2024 $189 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $189 |
| AstraZeneca Pharmaceuticals LP | 3 | $171 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| Exact Sciences Corporation | 2 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| ABBVIE INC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: BREZTRI, KISUNLA, MOUNJARO, The Cologuard Plus Collection Kit, GEMTESA, Kerendia, TRELEGY ELLIPTA, SHINGRIX.
Industry payments across NY — which companies pay providers there.
